Which has the lower trailing P/E, DHR or NVO?

NVO has the lower trailing P/E: DHR trades at 34.63 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DHR or NVO?

Over the past five years, NVO grew revenue faster — DHR at a 1.97% CAGR versus NVO at 20.73%.

Does DHR or NVO pay a bigger dividend?

DHR yields 0.74% and NVO yields 3.83% based on trailing dividends and the latest price.

Is DHR or NVO more profitable?

NVO runs the higher net margin — DHR at 15.95% versus NVO at 37.14%.

How have DHR and NVO total returns compared?

Over the past 10 years, DHR delivered 11.01% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Danaher Corporation (DHR) vs Novo Nordisk A/S (NVO)

A side-by-side comparison of Danaher Corporation and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 2, 2026. Differences are shown without an overall score or investment verdict.

DHR

Danaher Corporation

$137.13B

$194.98HealthcareAt close: Jul 31, 2026, 4:00 PM ET

NVO

Novo Nordisk A/S

$209.19B

$47.08HealthcareAt close: Jul 31, 2026, 4:00 PM ET

Total return — DHR vs NVO

growth of $100 · dividends reinvested · last 30y

DHR +6279.8%NVO +10806.6%NVO compounded faster

DHR NVO

DHR vs NVO: by the numbers

•NVO is the larger company ($209.19B vs $137.13B market cap).
•NVO trades at the lower trailing earnings multiple (11.01 vs 34.63 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (37.14% vs 15.95% net margin).
•NVO grew revenue faster over the past five years (20.73% vs 1.97% CAGR).
•NVO pays the higher dividend yield (3.83% vs 0.74%).

Metrics side by side

Valuation

Metric	DHR	NVO
P/E ratio	34.63	11.01
Forward P/E	22.96	N/A
P/S ratio	5.50	4.09
P/B ratio	2.62	6.69
PEG ratio	86.58	8.16
EV / EBITDA	24.40	8.62
FCF yield	3.96%	2.31%

Profitability

Metric	DHR	NVO
Gross margin	58.51%	81.83%
Operating margin	20.42%	45.21%
Net margin	15.95%	37.14%
ROE	7.61%	60.74%
ROIC	5.72%	29.53%

Dividends

Metric	DHR	NVO
Dividend yield	0.74%	3.83%
Payout ratio	28.40%	49.80%

Growth (annualized)

Metric	DHR	NVO
Revenue CAGR (5Y)	1.97%	20.73%
EPS CAGR (5Y)	0.40%	19.59%
FCF CAGR (5Y)	-2.83%	-5.86%
Total return CAGR (5Y)	-5.40%	2.46%

Frequently asked

Which has the lower trailing P/E, DHR or NVO?: NVO has the lower trailing P/E: DHR trades at 34.63 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DHR or NVO?: Over the past five years, NVO grew revenue faster — DHR at a 1.97% CAGR versus NVO at 20.73%.
Does DHR or NVO pay a bigger dividend?: DHR yields 0.74% and NVO yields 3.83% based on trailing dividends and the latest price.
Is DHR or NVO more profitable?: NVO runs the higher net margin — DHR at 15.95% versus NVO at 37.14%.
How have DHR and NVO total returns compared?: Over the past 10 years, DHR delivered 11.01% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DHR analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

Danaher P/E ratio Novo Nordisk A/S P/E ratio Danaher dividend yield Novo Nordisk A/S dividend yield Danaher ROE Novo Nordisk A/S ROE Danaher operating margin Novo Nordisk A/S operating margin Danaher revenue growth Novo Nordisk A/S revenue growth Danaher free cash flow Novo Nordisk A/S free cash flow

Danaher & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 2, 2026.